United Therapeutics (UTHR) Invested Capital (2009 - 2025)

United Therapeutics has disclosed Invested Capital across 17 years of filings, most recently posting $7.1 billion for Q4 2025.

• In Q4 2025, Invested Capital rose 5.22% year-over-year to $7.1 billion; the TTM figure through Dec 2025 stood at $7.1 billion (up 5.22% YoY), while the FY2025 annual figure was $7.1 billion, up 5.22% from the prior year.
• Invested Capital came in at $7.1 billion for Q4 2025 at United Therapeutics, up from $6.6 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $7.2 billion in Q2 2025 to a low of $4.2 billion in Q1 2021.
• Average Invested Capital over 5 years is $5.9 billion, with a median of $6.1 billion recorded in 2024.
• Year-over-year, Invested Capital increased 21.44% in 2023 and dropped 0.22% in 2024.
• Over 5 years, Invested Capital stood at $4.8 billion in 2021, then increased by 17.6% to $5.6 billion in 2022, then increased by 19.44% to $6.7 billion in 2023, then rose by 0.89% to $6.7 billion in 2024, then advanced by 5.22% to $7.1 billion in 2025.
• Per Business Quant data, the three most recent Invested Capital figures were $7.1 billion in Q4 2025, $6.6 billion in Q3 2025, and $7.2 billion in Q2 2025.